CHEManager International

New CMI #Whitepaper Excellence in Pharmaceutical Distribution and the Critical Role of Good Distribution Practice (#GDP) - Sponsored by Biesterfeld Group Discover in our exclusive whitepaper how compliance with Good Distribution Practice (GDP) contributes significantly to the safety of #pharmaceuticals. Learn how companies in the pharmaceutical industry can improve their raw material sourcing through a strategic partnership with a distributor – efficiently, cost-effectively and reliably. Content of the Whitepaper ▶️ Basics of GDP for pharmaceutical raw materials: Get to know the core principles. ▶️ Importance of GDP guidelines: Understand the significance and how they are implemented in practice. ▶️ Administrative and logistical requirements of GDP: Get an overview of the most important processes. ▶️ Added value through expertise: Optimize your processes with a distributor’s advice, quality assurance, and regulatory know-how. Download this free whitepaper: https://lnkd.in/ehWXy6uV

Novartis Acquires Kate Therapeutics for $1.1 Billion Swiss #pharmaceutical giant Novartis has acquired Kate Therapeutics for $1.1 billion. The San Diego, US-headquartered preclinical stage #biotechnology company develops adeno-associated virus (AAV)-based gene therapies to treat inherited #neuromuscular diseases. The technology platforms developed by Kate Therapeutics integrate capsid and cargo technologies to deliver payloads to desired tissues, while potentially mitigating off-target effects to tissues such as the liver. This approach aims to improve both the efficacy and safety of gene therapies, opening potential possibilities for treating complex diseases previously difficult to address with current technologies, including inherited neuromuscular diseases. Kate Therape’ primary programs include preclinical candidates for Duchenne muscular dystrophy (DMD), facioscapulohumeral dystrophy (FSHD), and myotonic dystrophy type 1 (DM1). Read more on #CMI online: https://lnkd.in/eeFE7YQh

Don´t forget our #Bioprocess Forum: Continuous & Automated #Bioprocessing This multi-day event will explore the latest trends and research in the field, including advancements in automation, emphasis on modular and scalable systems, and the increased use of real-time analytics. Event start: 10.12.2024 - 14:00 Event end: 12.12.2024 - 19:00 Learn about modular systems, automation, and continuous manufacturing with experts at our virtual event on December 10th – 12th. Whether you're optimizing workflows or advancing scalability, this is your chance to dive into the future of biomanufacturing. Sign up today! Register now to reserve your spot! https://lnkd.in/eRFS46Hu #biomanufacturing

Avantor Opens New US Innovation Center in Bridgewater Avantor has opened its latest Innovation Center in Bridgewater, New Jersey, US, “to support the growing demands for monoclonal #antibodies, cell and gene therapy and #mRNA workflows.” The new center is now part of the company’s network of 13 global research and #innovation centers. With the new center, which spans 60,000 square feet, Avantor has doubled its previous laboratory and pilot plant capacity. Designed for collaborative work, the facility includes spaces for upstream and downstream process development, dedicated analytical testing labs, and a viral vector laboratory. An expanded pilot plant supports scale-up simulations, enabling rapid customization across the entire #bioprocessing workflow, Avantor said. Michael Stubblefield, CEO of the US-headquartered contract development and manufacturing organization (#CDMO), commented: "Working side-by-side with customers in our network of innovation centers across the globe enables us to power science at every step to deliver life-changing therapies faster, and more cost effectively." Read more on #CMI online: https://lnkd.in/edf4YSaV

🧡 💙 ❤️ ... We are very proud 🙂 of our long-standing #partnership with CHEManager and CHEManager International. The 9th ECP, ECP - The First Industry Speed Dating Event or known as European Chemistry Partnering, will again be extensively publicized by the editorial team around Michael Reubold, editor in chief. 🧡 💙 ❤️ In addition, the three winners of the #CHEManager #Innovation #Pitch will be presented again next February in Frankfurt at the 9th #ECP: three start-ups that made it to first place in the categories “Value to #Society”, “Value to #Industry” and “Value to #Sustainability” after being evaluated by the jury. Of course, all participating startups in the CHEManager Innovation Pitch are invited to take part in the ECP live in Frankfurt and digitally two weeks later. 🧡 💙 ❤️ The #network of the ECP community is incredibly good. 💪 Thorsten Kritzer | Andrea Gruß | Beate Zimmermann | Stefan Guertzgen | Birgit Megges | Ralf Kempf | Volker Oestreich | Dr. Jörg Wetterau | Hafen Straubing-Sand | RUHR-IP Patentanwälte (in Bürogemeinschaft) | Siemens | BCNP Consultants GmbH | Tanja Dr. Bendele, LL.M. | Jan Käppler | Wagenhals Bettina | Ann-Kathrin Wagner | Thomas Luck | Sophia Friedel | Sven Kempf

#ISC3 Start-up of the Month for November 2024 DNACotton –Tracing the Journey of Your Fabrics and Their Sustainability Aspects DNACotton is a female-led start-up from Türkiye that has developed a blockchain-based labeling and traceability system for textiles. The solution allows for reliable monitoring and analysis of materials, from fiber production to customer delivery. The #startup creates unique genetic codes for each raw material, enabling the gapless information about the product’s entire value chain. This way, effective product tracking will help to ensure that materials are sourced responsibly, and workers' and consumers' safety is protected. With this approach, DNACotton not only promotes a circular economy but also discloses the support of fair labor practices and adaptation of humane working conditions in the textile industry. The textile industry significantly impacts climate change, pollution, and biodiversity loss. Gözde Bayer, R&D technical coordinator of the DNACotton located at Ankara University Technopolis, also recognized a pressing need for improved traceability and sustainability in the textile industry. In collaboration with İskur Tekstil Inc., Kahramanmaraş. her team embarked on the journey of developing a solution. The innovative project DNABarkod is underway to implement a robust traceability system using synthetic DNA #nanoparticles and Quick Response (QR) codes. This technology enables a dual/simultaneous verification process to ensure product authenticity and traceability, significantly reducing counterfeiting while improving supply chain transparency. The synthesized DNA, free of GMOs and safe for human health, will be embedded in textiles, creating unique identifiers for each product. Furthermore, the team developed a software solution combined with a cloud system, that connects the QR code on the product with the genetic code on the nanoparticle. During all stages of the production process, the code is scanned and saved in the databank. This way, gapless information about the whole lifecycle of a product is created. The whole success story of the International Sustainable Chemistry Collaborative Centre (ISC3) Start-up of the Month in November 2024 is currently told by the ISC3 on #CMI online: https://lnkd.in/eSCer7ia

Siegfried Opens New Drug Substances R&D Center in Evionnaz Zofingen, Switzerland-based contract development and manufacturing organization (#CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, #Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow #chemistry, advanced #distillation and process analytical technology, as well as new office space. Together with the R&D center in Zofingen, it will offer chemical process R&D and analytical development services for Siegfried's global drug substances network. With workspaces for over 100 specialists and 40 new jobs created, the R&D center strengthens Siegfried’s development capabilities in phase II and III supporting the company's Evolve+ strategy, the company said. Read more on #CMI online:

Three weeks to go!! Our last BioProcess Forum of the year is going to be a big one. Learn about modular systems, automation, and continuous manufacturing with experts at our free virtual event on December 10th – 12th. Whether you're optimizing workflows or advancing scalability, this is your chance to dive into the future of biomanufacturing. Sign up today! https://lnkd.in/eZcNsbkZ